BrightSpring Health Services, Inc. (BTSG) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.38%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 2.94×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.38% | Share-based compensation / revenue. Period ending 2026-06-30. $54.78M ÷ $14.37B × 100 ≈ 0.38% |
| Interest coverage · 12 months | 2.94× | Operating income ÷ reported interest expense. $447.80M ÷ $152.26M ≈ 2.94× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 14.37B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 54.78M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 447.80M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 152.26M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $14.37B | $54.78M | $447.80M | $152.26M | (m) | 0.38% | 2.94× | Reported |
| 2026-03-31 | (m) | $13.65B | $58.09M | $365.96M | $154.16M | (m) | 0.43% | 2.37× | Reported |
| 2025-12-31 | (m) | $12.91B | $70.10M | $295.25M | $157.31M | (m) | 0.54% | 1.88× | Reported |
| 2025-09-30 | (m) | $12.11B | $69.71M | $242.68M | $164.96M | (m) | 0.58% | 1.47× | Reported |
| 2025-06-30 | (m) | $11.37B | $67.67M | $183.93M | $173.34M | (m) | 0.59% | 1.06× | Reported |
| 2025-03-31 | (m) | $11.86B | $60.01M | $272.45M | $215.68M | (m) | 0.51% | 1.26× | Reported |
| 2024-12-31 | (m) | $11.27B | $69.17M | $206.37M | $228.39M | (m) | 0.61% | 0.90× | Reported |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $8.83B | $3.92M | $147.18M | $324.59M | (m) | 0.04% | 0.45× | Reported |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $7.72B | $3.55M | $187.83M | $233.58M | (m) | 0.05% | 0.80× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHEMED CORP (CHE) | United States | $6.474B | 22.14 |
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |